pharma · Chronic Spontaneous Urticaria · Asthma
Novartis India
Novartis Pharmaceuticals
Novartis Pharmaceuticals is a pharma organization headquartered in CN. Primary therapeutic focus areas include Chronic Spontaneous Urticaria, Asthma, Systemic Lupus Erythematosus, Breast Cancer, Multiple Sclerosis. NovaP
Mumbai, IN HQ
1996 Founded
2,240 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Mumbai, IN
- Founded
- 1996
- Employees
- 2,240
- Programs
- 341
- Drugs
- 317
- Patents
- 0
Secukinumab s.c. injection
Approved · mab · Autoimmunity, Inflammation
Secukinumab s.c. injection for Autoimmunity, Inflammation is a Approved program (mab) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code CAIN457A02001B
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Novartis Pharmaceuticals
- Phase
- Approved
- Modality
- mab
- Indication
- Autoimmunity, Inflammation
- Status
- active
- Trials
- 1